Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/dose-individualisation-in-patients-with-renal-insufficiency-does-drug-614UCoJv9b
References (19)
-
Jason Lazarou, B. Pomeranz, Paul Corey (1998)
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.JAMA, 279 15
-
H. Jick (1977)
Adverse drug effects in relation to renal function.The American journal of medicine, 62 4
-
P. Marroum, J. Gobburu (2002)
The Product LabelClinical Pharmacokinetics, 41
-
W. Mullen, I. Anderson, S. Kim, P. Blanc, K. Olson (1997)
Incorrect overdose management advice in the Physicians' Desk Reference.Annals of emergency medicine, 29 2
-
S. Vožeh, O. Schmidlin, W. Taeschner (1988)
Pharmacokinetic Drug DataClinical Pharmacokinetics, 15
-
(1999)
Therapeutic drugs -
Anil Rajpal, M. Reidenberg (2003)
Drug labeling should be kept currentClinical Pharmacology & Therapeutics, 73
-
PJ Marroum, J Gobburu (2002)
The product label: how pharmacokinetics and pharmacodynamics reach the prescriberClin Pharmacokinet, 41
-
L. Dettli (1984)
The Kidney in Pre-Clinical and Clinical PharmacokineticsRinsho Yakuri\/japanese Journal of Clinical Pharmacology and Therapeutics, 15
-
D. Bates, D. Cullen, N. Laird (1995)
Incidence of adverse drug events and potential adverse drug eventsInternational Journal of Trauma Nursing, 1
-
AD Falconnier, WE Haefeli, RA Schoenenberger, C Surber, M Martin-Facklam (2001)
Drug dosage in patients with renal failure optimized by immediate concurrent feedbackJ Gen Intern Med, 16
-
D. Bates, D. Cullen, N. Laird, L. Petersen, S. Small, D. Servi, G. Laffel, B. Sweitzer, B. Shea, R. Hallisey (1995)
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for PreventionJAMA, 274
-
V. Bergk, C. Gasse, R. Schnell, W. Haefeli (2004)
Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in GermanyEuropean Journal of Clinical Pharmacology, 60
-
D. Connelly, E. Rich, S. Curley, J. Kelly (1990)
Knowledge resource preferences of family physicians.The Journal of family practice, 30 3
-
(2002)
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney disease outcome quality initiative. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney diseaseAm J Kidney Dis, 39
-
D. Spyker, E. Harvey, B. Harvey, Alan Harvey, B. Rumack, C. Peck, A. Atkinson, R. Woosley, D. Abernethy, L. Cantilena (2000)
Assessment and reporting of clinical pharmacology information in drug labelingClinical Pharmacology & Therapeutics, 67
-
S. Pestotnik, D. Classen, R. Evans, Lane Stevens, J. Burke (1993)
Prospective Surveillance of Imipenem/Cilastatin Use and Associated Seizures Using a Hospital Information SystemAnnals of Pharmacotherapy, 27
-
A. Levey, J. Coresh, K. Bolton, B. Culleton, K. Harvey, T. Ikizler, C. Johnson, A. Kausz, P. Kimmel, J. Kusek, A. Levin, K. Minaker, R. Nelson, H. Rennke, M. Steffes, B. Witten, R. Hogg, S. Furth, K. Lemley, R. Portman, G. Schwartz, J. Lau, E. Balk, R. Perrone, T. Karim, Lara Rayan, Inas Al-Massry, P. Chew, B. Astor, De Vine, G. Eknoyan, N. Levin, S. Burrows‐Hudson, W. Keane, A. Kliger, D. Latos, D. Mapes, E. Oberley, K. Willis, G. Bailie, G. Becker, J. Burrowes, D. Churchill, A. Collins, W. Couser, D. Dezeeuw, A. Garber, T. Golper, F. Gotch, A. Gotto, J. Greer, R. Grimm, R. Hannah, J. Acosta, L. Hunsicker, M. Klag, S. Klahr, C. Lewis, E. Lowrie, A. Matas, S. McCulloch, Maureen Michael, J. Nally, J. Newmann, A. Nissenson, Keith Norris, W. Owen, T. Patel, G. Payne, R. Rivera-Mizzoni, David Smith, R. Star, T. Steinman, F. Valderrábano, J. Walls, J. Wauters, N. Wenger, J. Briggs (2002)
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.American journal of kidney diseases : the official journal of the National Kidney Foundation, 39 2 Suppl 1
-
L Dettli (1984)
The kidney in pre-clinical and clinical pharmacokineticsJpn J Clin Pharmacol Ther, 15
- Publisher
- Springer Journals
- Copyright
- Copyright © 2004 by Springer-Verlag
- Subject
- LifeSciences
- ISSN
- 0031-6970
- eISSN
- 1432-1041
- DOI
- 10.1007/s00228-004-0852-y
- pmid
- 15599503
- Publisher site
- See Article on Publisher Site
Abstract
When renal failure had no impact on dosing, information was often missing. Such information is however important to differentiate, whether no dose adaptation is necessary or no information is available. If dose adjustment is required, application of a uniform concept is desirable.
Journal
European Journal of Clinical Pharmacology – Springer Journals
Published: Dec 14, 2004